The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Down 25.0% in September

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 8,100 shares, a decline of 25.0% from the September 15th total of 10,800 shares. Based on an average daily volume of 22,400 shares, the short-interest ratio is presently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Up 0.7 %

Shares of Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded up $0.14 during trading on Friday, hitting $19.98. 10,575 shares of the company were exchanged, compared to its average volume of 22,062. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a fifty-two week low of $15.90 and a fifty-two week high of $20.85. The firm has a 50 day moving average price of $19.53 and a 200 day moving average price of $18.84.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, November 1st will be given a dividend of $0.2891 per share. The ex-dividend date of this dividend is Friday, November 1st. This represents a $1.16 annualized dividend and a dividend yield of 5.79%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.